EUVIMEDEUVIMED entdecken
Crossref

Long Term Outcomes After Percutaneous Coronary Intervention in Patients With Lymphoma: A Propensity-Matched Analysis

Isabel C Reeves, Jessica G Laenger, Brad R Lewis, Nahyr Lugo-Fagundo, Jordan C Ray, Joerg Herrmann iD, Alyssa D McPherson, Sidney Bianco, Mandeep Singh iD, Abdallah El Sabbagh, Dilip P Pillai, Pragnesh P Parikh und 3 weitere

Cardiology · 07.11.2026

DOI: 10.1159/crd/absag032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology, online erschienen am 07.11.2026. Verfasst von Isabel C Reeves und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with a history of lymphoma may develop significant coronary artery disease (CAD), which may be treated by percutaneous coronary intervention (PCI), yet long term outcomes are not well characterized.

Methods

We reviewed patients with a history of lymphoma undergoing PCI from our institutional PCI database and compared characteristics and outcomes to a cohort without cancer. Long-term mortality and major adverse cardiac events (MACE) (cardiac death, myocardial infarction (MI), target vessel revascularization (TVR)) were assessed.

Results

Of the 11,953 patients identified, 83 (0.7%) had past or current lymphoma. Most had Diffuse large B-cell lymphoma (DLBCL) (n=23; 28.8%) or Hodgkin’s Lymphoma (HL) (n=22; 27.%), and 31 (37.3%) presented with acute coronary syndrome. Lymphoma patients, as compared to non-lymphoma patients, were similar with respect to age, sex, hypertension, diabetes, hyperlipidemia, prior MI, and prior PCI (all p=ns). The 1, 3, and 5-year survival rates were 90.5%, 69.5 %, and 52.5% in lymphoma patients as compared to 88.0%, 77.1%, and 66.7% in propensity matched non-lymphoma controls. Lymphoma was an independent predictor of mortality (OR 1.59; 95% CI 1.07-2.36, p=0.02) after multivariable adjustment. In propensity matched analysis over a median follow up of 4.2 years (IQR 1.28, 7.73), lymphoma was not independently associated with worse survival or MACE.

Conclusions

Among patients with CAD undergoing PCI, <1% had previous or active lymphoma. Although lymphoma may appear predictive of mortality in regression models with multivariable adjustment, mortality and MACE rates are similar to propensity matched controls.

Autor:innen und Institutionen

ORCID-Profile: Joerg Herrmann, Mandeep Singh

Zitieren

APA

Reeves, I. C., Laenger, J. G., Lewis, B. R., Lugo-Fagundo, N., Ray, J. C., Herrmann, J., McPherson, A. D., Bianco, S., Singh, M., El Sabbagh, A., Pillai, D. P., Parikh, P. P., Reddy, P., Sher, T., & Gharacholou, S. M. (2026). Long Term Outcomes After Percutaneous Coronary Intervention in Patients With Lymphoma: A Propensity-Matched Analysis. Cardiology. https://doi.org/10.1159/crd/absag032

Vancouver

Reeves IC, Laenger JG, Lewis BR, Lugo-Fagundo N, Ray JC, Herrmann J, et al. Long Term Outcomes After Percutaneous Coronary Intervention in Patients With Lymphoma: A Propensity-Matched Analysis. Cardiology. 2026. doi:10.1159/crd/absag032

BibTeX
@article{Reeves2026,
  author = {Reeves, Isabel C and Laenger, Jessica G and Lewis, Brad R and Lugo-Fagundo, Nahyr and Ray, Jordan C and Herrmann, Joerg and McPherson, Alyssa D and Bianco, Sidney and Singh, Mandeep and El Sabbagh, Abdallah and Pillai, Dilip P and Parikh, Pragnesh P and Reddy, Prajwal and Sher, Taimur and Gharacholou, S Michael},
  title = {Long Term Outcomes After Percutaneous Coronary Intervention in Patients With Lymphoma: A Propensity-Matched Analysis},
  journal = {Cardiology},
  year = {2026},
  doi = {10.1159/crd/absag032}
}
Kostenlos starten →